ahmet ziya şahin

Dr. ahmet ziya şahin

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AŞahmet ziya şahin
ahmet ziya şahin
OÖOrhan Özdemir
Orhan Özdemir
Inflammation plays a crucial role in the progression of autosomal dominant polycystic kidney disease (ADPKD). While tolvaptan is primarily known for its vasopressin V2 receptor antagonism, its potential anti-inflammatory effects remain under investigation. This study aimed to evaluate the impact of tolvaptan on inflammatory markers and renal progression in ADPKD patients. This retrospective, two-center cohort study included 80 ADPKD patients, with 40 receiving tolvaptan and 40 serving as controls. Inflammatory markers, including C-reactive protein (CRP), systemic inflammatory index (SII), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and renal function parameters such as glomerular filtration rate (GFR) and proteinuria, were analyzed over a 1-year follow-up period. In the tolvaptan group, CRP, SII, PLR, proteinuria, and uric acid levels significantly decreased, whereas these markers increased in the control group. GFR remained stable in the tolvaptan group but declined significantly in the control group (p < 0.001). No significant correlation was found between GFR and inflammatory markers in either group. Our findings suggest that tolvaptan may contribute to reducing systemic inflammation in ADPKD patients while preserving renal function. These results align with previous studies indicating a link between inflammation and ADPKD progression.

25 October 2023 in Genel Tıp Dergisi
Verified
Journal Article
Open access
AŞahmet ziya şahin
ahmet ziya şahin
NÖNurgül Özdemi̇r
Nurgül Özdemi̇r
Şengül Kocamer ŞahinŞengül Kocamer Şahin
Şengül Kocamer Şahin
BDBahadir Demir
Bahadir Demir
Background/Aims: Poor sleep quality in hemodialysis patients causes a decrease in quality of life. In this study we aimed to investigate the relationship between sleep quality, and depression, death anxiety and perceived pain. Methods: A total of 101 patients with chronic kidney disease (CKD) under hemodialysis were included in this cross-sectional study. The assessment tools were Beck Depression Inventory (BDI), Death Anxiety Scale (DAS), Pittsburgh Sleep Quality Index (PSQI), and Visual Analogue Scale (VAS). Results: The mean age of the patients was 51.9±13.1. Ninety six (95%) patients had a PSQI score of 6 or above that indicates poor sleep quality. 64.4% of the patients had mild to severe depressive symptoms in terms of BDI. There were significant correlations between PSQI and DAS (r: 0.382), and VAS (r: 0.261), and BDI (r: 0.483). Conclusion: Poor sleep quality is a common problem in hemodialysis patients. Death anxiety, pain and depression are associated with poor sleep in hemodialysis patients. It is recommended to consider poor sleep quality to provide appropriate treatment.

1 April 2020 in Archives of Clinical Psychiatry (São Paulo)
Verified
Journal Article
Open access
PDF file
Şengül Kocamer ŞahinŞengül Kocamer Şahin
Şengül Kocamer Şahin
CYCelal Yaşamali
Celal Yaşamali
MÖMuhammet Berkay Özyürek
Muhammet Berkay Özyürek
GEGULCIN ELBOGA
GULCIN ELBOGA
AAAbdurrahman Altindağ
Abdurrahman Altindağ
AŞahmet ziya şahin
ahmet ziya şahin
Background: There is growing evidence of subclinical inflammation in mental disorders. Objective: The aim of this study was to investigate frequency of symptoms of catatonia and the newly diagnosed subclinical inflammatory markers which are neutrophil/lymphocyte (NLR), platelet/lymphocyte (PLR), monocyte/lymphocyte (MLR) ratios in catatonia patients due to mental disorders. Methods: Patients who were admitted to psychiatry clinic with the diagnosis of catatonia according to DSM 5 in the last two years and equal number of control group were included in this retrospective study. Univariate analysis of covariance controlled for possible confounders was used to compare NLR, PLR, MLR ratios between patients and the control group. Results: A total of 34 catatonia patients and 34 healthy controls were included in the study. Patients' mean age was 30.88 + 13.4. NLR value was significantly higher in the patient group than control group. There was no significant difference between the patients and control group according to PLR, MLR values. Discussion: The presence of subclinical inflammation in catatonic syndrome due to mental disorders should be considered. Subclinical inflammation that was observed in numerous mental disorders continues in catatonia due to mental disorders. Large-scale studies are needed to determine the role of inflammation in catatonia.

1 March 2022 in Transplant Immunology
Verified
Journal Article
Closed access
ÖUÖzlem Usalan
Özlem Usalan
AŞahmet ziya şahin
ahmet ziya şahin
OÖOrhan Özdemir
Orhan Özdemir
MCMukaddes Cingöz
Mukaddes Cingöz
CUCelalettin Usalan
Celalettin Usalan

8 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MÖMurat ÖZDEDE
Murat ÖZDEDE
SYSerap Yadigar
Serap Yadigar
AGAlper Tuna Guven
Alper Tuna Guven
SASuat Akgür
Suat Akgür
FAFelemez ARSLAN
Felemez ARSLAN
EBElif Arı Bakır
Elif Arı Bakır
Background: Finerenone is associated with a lower, yet clinically relevant, risk of hyperkalemia compared with steroidal mineralocorticoid receptor antagonists in diabetic kidney disease (DKD) trials. However, real-world data on hyperkalemia and its associated factors are lacking. Methodology: FINE-TURK is a national, observational cohort of DKD patients who were initiated on finerenone. Eligible adults were included; demographic, clinical, and laboratory data were evaluated. The primary outcome (PO) was hyperkalemia risk signal (potassium ≥ 5.0 mEq/L), and the secondary outcome (SO) was clinically meaningful hyperkalemia (potassium ≥ 5.5 mEq/L). Multivariate logistic regression (LR) was used to define features associated with both PO and SO. LR, random forest (RF), gradient boosting, and CatBoost classifiers were used to define important features associated with the PO. Results: 699 patients were included. 259 (37.1%) reached the PO, and 51 (7.3%) reached the SO. Baseline potassium and estimated glomerular filtration rate (eGFR) were the most important variables associated with both outcomes and were consistently identified as the top features across all models. Thiazide use, presence of diabetic retinopathy, and diabetes duration were also associated with the PO. LR demonstrated the highest recall; random forest achieved the highest precision in performance. Discussion: Real-world data suggest that the risk of clinically meaningful hyperkalemia is similar to that in the clinical trials. In parallel with the safety analysis of clinical trials, baseline potassium and eGFR were consistently the most important factors associated with hyperkalemia risk.

26 May 2023 in New Trends in Medicine Sciences
Verified
Journal Article
Open access
YTYunus Emre Topdaği
Yunus Emre Topdaği
ÇDÇağdaş Demi̇rOğlu
Çağdaş Demi̇rOğlu
AŞahmet ziya şahin
ahmet ziya şahin
Background: Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. Early diagnosis and treatment are important; the condition can cause both maternal and foetal complications. Today, single-/double-bolus oral 50–100-g glucose tolerance tests (OGTTs) are preferred. We explored whether the peripheral blood platelet/lymphocyte ratio (PLR) and/or neutrophil/lymphocyte ratio (NLR) could guide diabetes screening of a target group (rather than all pregnant women). Materials and Methods: This retrospective study was conducted at the Obstetrics and Gynecology Clinic of Sanko University Hospital from January 2010 to January 2020. Pregnant women in gestational weeks 24 to 28 who underwent 75-g OGTTs were included. Patients were evaluated by dividing them into two groups. Group 1 included 300 women with GDM. Group 2 included 300 healthy pregnant women who were negative on the OGTT test. We retrieved patient ages, gestational weeks, all blood count data derived during pregnancy, fasting blood glucose levels, heights and weights, and body mass indices. Results: Leukocyte and neutrophil counts were significantly higher in the diabetic patient group than in the control group (both p < 0.01). The NLR and PLR differed significantly between the two groups (both p < 0.01), but the demographic data did not. Conclusion: Increase in white blood cell count, and elevations in the PLR and NLR, independently predicted GDM. Blood NLR and PLR can also be used as a GDM screening test. The NLR and PLR (markers of inflammation) were significantly increased in pre-diabetic and diabetic patients. The NLR and PLR may usefully predict pre-diabetes and GDM.